Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
Clinical trial NCT02770807 · COMPLETED
Trial details
- NCT number
- NCT02770807
- Sponsor
- Quince Therapeutics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2021-05-13
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.